| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 7.027 | 40.816 | 93.581 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 7.027 | 40.816 | 94.144 |
| Total Expenses - EUR | - | - | - | - | - | - | 46 | 5.315 | 17.634 | 61.139 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -46 | 1.712 | 23.182 | 33.005 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -46 | 1.506 | 22.823 | 30.519 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Hepatoendomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 2.145 | 1.434 | 715 | 62.200 |
| Current Assets | - | - | - | - | - | - | 177 | 1.304 | 24.308 | 22.381 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 40 | 406 | 0 | -5 |
| Cash | - | - | - | - | - | - | 137 | 899 | 24.308 | 22.386 |
| Shareholders Funds | - | - | - | - | - | - | -5 | 1.500 | 24.318 | 32.588 |
| Social Capital | - | - | - | - | - | - | 0 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 2.328 | 1.238 | 722 | 51.992 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Hepatoendomed S.r.l.